Evidence map›Paper›PMID 19416828›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Schizosaccharomyces pombe Rtf2 mediates site-specific replication termination by inhibiting replication restart.

Takabumi Inagawa, Tomoko Yamada-Inagawa, Trevor Eydmann, I Saira Mian, Teresa S Wang, Jacob Z Dalgaard

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. eLife · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Genes · 2020
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Maintaining genome stability at the replication fork.Nature reviews. Molecular cell biology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Takabumi InagawaMarie Curie Research Institute, The Chart, Oxted, Surrey RH8 0TL, United Kingdom.
Tomoko Yamada-Inagawa
Trevor Eydmann
I Saira Mian
Teresa S Wang
Jacob Z Dalgaard
Marie Curie · GBLawrence Berkeley National Laboratory · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we identify a phylogenetically conserved Schizosaccharomyces pombe factor, named Rtf2, as a key requirement for efficient replication termination at the site-specific replication barrier RTS1. We show that Rtf2, a proliferating cell nuclear antigen-interacting protein, promotes termination at RTS1 by preventing replication restart; in the absence of Rtf2, we observe the establishment of "slow-moving" Srs2-dependent replication forks. Analysis of the pmt3 (SUMO) and rtf2 mutants establishes that pmt3 causes a reduction in RTS1 barrier activity, that rtf2 and pmt3 are nonadditive, and that pmt3 (SUMO) partly suppresses the rtf2-dependent replication restart. Our results are consistent with a model in which Rtf2 stabilizes the replication fork stalled at RTS1 until completion of DNA synthesis by a converging replication fork initiated at a flanking origin.

Indexed as

Amino Acid MotifsAmino Acid SequenceDNA-Binding ProteinsDNA ReplicationGene Expression RegulationGenome, FungalMolecular Sequence DataMutationPhenotypePlasmidsProliferating Cell Nuclear AntigenSchizosaccharomycesSchizosaccharomyces pombe ProteinsSequence Homology, Amino AcidSmall Ubiquitin-Related Modifier ProteinsTwo-Hybrid System TechniquesDNA-Binding ProteinsProliferating Cell Nuclear AntigenRtf2 protein, S pombeSchizosaccharomyces pombe ProteinsSmall Ubiquitin-Related Modifier Proteins

Identifiers

PMID19416828
PMCPMC2683088
OpenAlexW2019862127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.